This article is more than 5 years old. Information may no longer be current.

First Argus II procedure in Asia performed

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Argus II retinal prosthesis system has been implanted in the first patient in Asia at the Chang Gung Memorial Hospital in Taiwan, according to a Second Sight press release.

Argus II, which provides electrical stimulation of viable retinal cells to induce visual perception in patients with profound retinitis pigmentosa, has been previously approved and offered in several countries worldwide, including the U.S., as well as Canada, France, Germany, Italy, Netherlands, Saudi Arabia, Spain, Switzerland, Turkey and the United Kingdom.

The system was made available for use in Asia through a partnership between Second Sight and Orient Europharma Co. Ltd., along with charitable support from the Hong-Lu Foundation in Taiwan.

“We are very pleased to expand the availability of the Argus II to Asia as we continue to offer our technology to patients with retinitis pigmentosa, providing them with the potential opportunity to lead more independent lives,” Will McGuire, president and CEO of Second Sight, said in the release.